Shares of minimally invasive medical products provider InMode (NASDAQ:INMD) are soaring today on the company’s better-than-anticipated preliminary third-quarter numbers.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Revenue is seen lading between $120.5 million and $120.9 million, significantly ahead of the ~$106 million anticipated mark.
Further, bottom-line is seen landing between $0.64 and $0.65 per share.
Looking ahead, for the full year, InMode expects its top line to hover between $445 million and $450 million.
Read full Disclosure